Nocturnal hemodialysis: three-year experience.

There is evidence that high frequency, as well as long duration, hemodialysis provides better clinical outcomes. We developed nocturnal hemodialysis, a new innovative form of renal replacement therapy, which is performed six to seven nights per week for 8 to 10 h during sleep at home. Blood flow was set at 300 ml/min and dialysate flow at 100 ml/min. An internal jugular catheter was used as the vascular access. Special precautions were taken to prevent accidental disconnection during sleep, as well as air embolization. Dialysis functions from the patient's home were monitored continuously via a modem at the nocturnal hemodialysis center. Twelve patients have completed training and have been successfully performing nocturnal hemodialysis for up to 34 mo. This study represents 170 patient months of experience accumulated over 3 yr. There was hemodynamic stability and significant subjective improvement in patient well being. Nightly Kt/V was 0.99. Weekly removal of phosphate was twice as high and beta2 microglobulin 4 times as high as conventional hemodialysis. All patients have discontinued their phosphate binders and have increased dietary phosphate and protein intake. BP control was achieved with fewer medications. Dialyzer reuse has decreased the operating costs to the level of the other form of home dialysis. Complications were infrequent and were related primarily to the dialysis access. Nocturnal hemodialysis represents the most efficient form of dialysis at low cost and should be considered as an option for patients who can be trained for home hemodialysis.

[1]  R. Wolfe,et al.  Effect of the dialysis membrane on mortality of chronic hemodialysis patients. , 1996, Kidney international.

[2]  R M Hakim,et al.  Effects of dose of dialysis on morbidity and mortality. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Mortality and duration of hemodialysis treatment. , 1991, JAMA.

[4]  B. Charra,et al.  Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. , 1996, American journal of nephrology.

[5]  J T Daugirdas,et al.  The dose of hemodialysis and patient mortality. , 1996, Kidney international.

[6]  D. Goldsmith,et al.  Interdialysis blood pressure control by long haemodialysis sessions. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  L. Mailloux,et al.  The Impact of Co‐Morbid Risk Factors at the Start of Dialysis Upon the Survival of ESRD Patients , 1996, ASAIO journal.

[8]  F. Casino,et al.  The equivalent renal urea clearance: a new parameter to assess dialysis dose. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  P. Li,et al.  Effect of hemodialysis on protein C, protein S, and antithrombin III levels. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  C. Kjellstrand,et al.  The "unphysiology" of dialysis: a major cause of dialysis side effects? , 1975, Kidney international. Supplement.

[11]  P. Kimmel,et al.  Relative risk and economic consequences of inpatient care among patients with renal failure. , 1996, Journal of the American Society of Nephrology : JASN.

[12]  J A Sargent,et al.  A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). , 1985, Kidney international.

[13]  E. Friedman,et al.  The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. , 1996, The New England journal of medicine.

[14]  U. Buoncristiani,et al.  Daily dialysis: long-term clinical metabolic results. , 1988, Kidney international. Supplement.

[15]  F. Port End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions. , 1995, Kidney international. Supplement.

[16]  J. Kopple Effect of nutrition on morbidity and mortality in maintenance dialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  B. Pereira Effect of the Dialysis Membrane on Mortality of Chronic Hemodialysis Patients. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agadoa L. Kidney International 1996, 50:566–570 , 2008, Seminars in dialysis.

[18]  A. Bellucci,et al.  Mortality in dialysis patients: analysis of the causes of death. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  F. Port,et al.  Comparison of mortality with home hemodialysis and center hemodialysis: a national study. , 1996, Kidney international.

[20]  P Keshaviah,et al.  Urea index and other predictors of hemodialysis patient survival. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  M. Ferdeghini,et al.  Plasma parameters of the prothrombotic state in chronic uremia. , 1993, Nephron.

[22]  T. Ing,et al.  Increasing Plasma Phosphorus Values by Enriching with Phosphorus the “Acid Concentrate” of a Bicarbonate-Buffered Dialysate Delivery System , 1992, The International journal of artificial organs.

[23]  E G Lowrie,et al.  Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  B. Charra,et al.  Survival as an index of adequacy of dialysis. , 1992, Kidney international.

[25]  R. Fagugli,et al.  Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD). , 1996, Contributions to nephrology.

[26]  R. Wolfe,et al.  A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. , 1995, Journal of the American Society of Nephrology : JASN.

[27]  B. Lindholm,et al.  Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? , 1993, Kidney international. Supplement.